Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	63.27	72.17	44.20
Graham Fair Price	634.55	20.20	2.75
PEG	-99.96	< 0.005	-20.69
Price/Book	25.56	2.74	2.18
Price/Cash Flow	585.86	88.86	12.96
Prices/Earnings	-97.73	-44.42	1957.83
Price/Sales	51.48	2.72	1.80
Price/FCF	585.86	88.86	12.96
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.29	0.06	0.07
Operating Margin	-98.72	< 0.005	0.01
ROA	6002.42	< 0.005	< 0.005
ROE	< 0.005	-0.02	5434.00
ROIC	0.68	< 0.005	-99.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.10	0.06	73.49
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.78	-0.99	-27.36
EPS QOQ	-0.95	-55.64	-5780.83
FCF QOQ	0.78	-0.82	5.47
Revenue QOQ	< 0.005	-0.18	2460.52
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.18	4.01	26.23
Days Sales Outstanding (DSO)	85.78	96.99	13.06
Inventory Turnover	28.33	22.44	-20.78
Debt/Capitalization	0.53	0.50	-4.69
Quick Ratio	1.29	1.19	-7.32
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.75	34.31	-1.26
Cash	6.80	3.20	-52.96
Capex	-0.46	-0.33	28.63
Free Cash Flow	5.84	1.06	-81.92
Revenue	42.12	34.47	-18.15
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.40	1.31	-6.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.79	20.51	38.61
Naive Interpretation	Member

06 - Financial Health · Weak

Rating